Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, September 27, 2016

Public edition | newswise.com

American Society for Radiation Oncology (ASTRO) - News from the 58th Annual Meeting 27-Sep-2016
 

58th Annual Meeting of the American Society for Radiation Oncology (ASTRO)
September 25-28, 2016
Boston



Stereotactic Radiosurgery Decreases Rate of Post-Operative Local Recurrence for Brain Metastases

Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rate...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 25-Sep-2016 at 15:15 ET


Reduced Radiation Boost Volume Recommended but Craniospinal Axis Dose Remains Unchanged for Average-Risk Pediatric Medulloblastoma

In the largest trial conducted for average risk (A-R) medulloblastoma, survival rates following reduced radiation therapy (RT) boost volumes were comparable to standard treatment volumes for the primary tumor site but lower doses of craniospinal axis...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 25-Sep-2016 at 15:15 ET


Post-Operative Stereotactic Radiosurgery a New Standard of Care for Patients with Resected Brain Metastases

For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBR...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 25-Sep-2016 at 15:15 ET


Three Novel Intrinsic Subtypes of Prostate Cancer Identified

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients ...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 25-Sep-2016 at 15:15 ET


Hypofractionated Radiation Therapy Can Halve Treatment Time for Poor Performance Status Lung Cancer Patients

For patients with stage II and III non-small cell lung cancer (NSCLC) unable to receive standard treatments of surgery or chemoradiation (CRT), hypofractionated radiation therapy (RT) results in similar overall survival (OS) and progression-free sur...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 25-Sep-2016 at 10:00 ET


Advances in Radiation Therapy Have Improved Survival Rates for Early Stage Lung Cancer Patients

A new analysis of records in the Veteran’s Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell lung cancer (NSCLC) in ...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 25-Sep-2016 at 13:15 ET


Intervention Closes Racial Gap and Improves Treatment Rates for Early Stage Lung Cancer

Enhanced, culturally-competent communication with early stage lung cancer patients can narrow racial gaps in curative treatment completion and increase treatment rates for all races, according to research presented today at the 58th Annual Meeting of...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 26-Sep-2016 at 07:45 ET


Unmet Need for Radiation Therapy Found Among Nearly Half of Eligible Cancer Patients in Nine Developing Countries

Although approximately 50 percent of cancer patients in developing countries need radiation therapy (RT) to treat their disease, up to half of these patients do not have access to it, according to research presented today at the 58th Annual Meeting o...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 26-Sep-2016 at 07:45 ET


Cervical and Endometrial Cancer Patients Report Fewer Side Effects and Better Quality of Life with Imrt

Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 26-Sep-2016 at 14:15 ET


Hypofractionated RT Can Reduce Treatment Time by One-Third with Comparable QOL for Prostate Cancer Patients

For men with early stage, low-risk prostate cancer, treatment with hypofractionated radiation therapy (RT) offers comparable health-related quality of life outcomes in one-third less treatment time than conventional RT, according to research presente...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 26-Sep-2016 at 14:15 ET


Widespread Adoption of SBRT Has Improved Survival Rates for Elderly Patients with Early Stage Lung Cancer

Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, a...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 26-Sep-2016 at 10:30 ET


Radiation Therapy and Radical Prostatectomy Further Explored for Initial Diagnosis of Advanced Prostate Cancer

A database study examining surgical removal of the prostate gland (radical prostatectomy) or a form of radiation therapy known as IMRT to treat prostate cancer that has spread to other parts of the body (metastatic) shows an association between each ...

– Rutgers Cancer Institute of New Jersey

ASTRO Annual Meeting, Sept-2016


SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent cancer control rates, according to research presented today a...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 26-Sep-2016 at 07:45 ET


Extremely Hypofractionated Radiation Therapy Shows Promising Toxicity Results for Intermediate Risk Prostate Cancer Patients

For men with intermediate risk prostate cancer, side effects at two years following radiation therapy (RT) were comparable for extremely-hypofractionated treatment, which was delivered in seven fractions across two and a half weeks, and conventional ...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 26-Sep-2016 at 08:00 ET


Intermediate Risk Prostate Cancer May Be Well Controlled with Brachytherapy Alone

For men with intermediate risk prostate cancer, radiation treatment with brachytherapy alone can result in similar cancer control with fewer long-term side effects, when compared to more aggressive treatment that combines brachytherapy with external ...

– American Society for Radiation Oncology (ASTRO)

ASTRO Annual Meeting, Sep-2016

Embargo expired on 26-Sep-2016 at 14:15 ET

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application